Published 2019
| Version v1
Publication
dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice
Description
Colasante et al. exploit an activatory CRISPR-targeting Scn1a gene promoter as a therapeutic strategy to rescue Scn1a haploinsufficiency in a mouse model of Dravet syndrome and restore physiological levels of its gene product, the Nav1.1 voltage-gated sodium channel.
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/999413
- URN
- urn:oai:iris.unige.it:11567/999413
Origin repository
- Origin repository
- UNIGE